September 8, 2000 - Volume 14 - Issue 13
pp: 1879-2067
Subscribe to eTOC

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy

Bart, Pierre-Alexandre; Rizzardi, G. Paolo; Tambussi, Giuseppe; More

AIDS . 14(13):1887-1897, September 8, 2000.

Concise Communication

Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface

Shacklett, Barbara L; Cu-Uvin, Susan; Beadle, Thomas J; More

AIDS . 14(13):1911-1915, September 8, 2000.


Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection

Plana, Montserrat; García, Felipe; Gallart, Teresa; More

AIDS . 14(13):1921-1933, September 8, 2000.

Full suppression of viral load is needed to achieve an optimal CD4 cell count response among patients on triple drug antiretroviral therapy

Wood, Evan; Yip, Benita; Hogg, Robert S; More

AIDS . 14(13):1955-1960, September 8, 2000.

Concise Communication

Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine

Haas, David W; Arathoon, Eduardo; Thompson, Melanie A; More

AIDS . 14(13):1973-1978, September 8, 2000.


Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection

Girardi, Enrico; Antonucci, Giorgio; Vanacore, Paola; More

AIDS . 14(13):1985-1991, September 8, 2000.

Regional differences in HIV testing among European patients with sexually transmitted diseases: trends in the history of HIV testing and knowledge of current serostatus

Fennema, Han; van den Hoek, Anneke; van der Heijden, Johan; More

AIDS . 14(13):1993-2001, September 8, 2000.

CDC HIV prevention indicators: monitoring and evaluating HIV prevention in the USA

Rugg, Deborah L; Heitgerd, Janet L; Cotton, David A; More

AIDS . 14(13):2003-2013, September 8, 2000.